Xiqian Xing

752 total citations
62 papers, 398 citations indexed

About

Xiqian Xing is a scholar working on Pulmonary and Respiratory Medicine, Epidemiology and Molecular Biology. According to data from OpenAlex, Xiqian Xing has authored 62 papers receiving a total of 398 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Pulmonary and Respiratory Medicine, 20 papers in Epidemiology and 16 papers in Molecular Biology. Recurrent topics in Xiqian Xing's work include Pneumonia and Respiratory Infections (16 papers), Respiratory viral infections research (12 papers) and Pulmonary Hypertension Research and Treatments (12 papers). Xiqian Xing is often cited by papers focused on Pneumonia and Respiratory Infections (16 papers), Respiratory viral infections research (12 papers) and Pulmonary Hypertension Research and Treatments (12 papers). Xiqian Xing collaborates with scholars based in China. Xiqian Xing's co-authors include Shuanglan Xu, Jiao Yang, Xiudi Han, Chunxiao Zhang, Liang Chen, Yanli Li, Chunfang Zhang, Yishu Deng, Shangjie Wu and Ye Gan and has published in prestigious journals such as CHEST Journal, Emerging infectious diseases and International Journal of Pharmaceutics.

In The Last Decade

Xiqian Xing

58 papers receiving 396 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiqian Xing China 12 163 126 114 74 60 62 398
Xin Feng China 14 301 1.8× 235 1.9× 78 0.7× 142 1.9× 64 1.1× 31 522
Goh Tanaka Japan 11 149 0.9× 104 0.8× 82 0.7× 38 0.5× 16 0.3× 43 376
Shigenori Tamaki Japan 11 118 0.7× 111 0.9× 117 1.0× 28 0.4× 31 0.5× 17 480
Yunjoo Im South Korea 12 246 1.5× 78 0.6× 154 1.4× 28 0.4× 27 0.5× 41 487
Ying Feng China 12 55 0.3× 81 0.6× 55 0.5× 30 0.4× 30 0.5× 30 380
Sang-Min Kim South Korea 7 82 0.5× 61 0.5× 54 0.5× 49 0.7× 116 1.9× 31 315
Ryan Brown United Kingdom 8 142 0.9× 63 0.5× 89 0.8× 35 0.5× 16 0.3× 13 395
Tsutomu Hachiya Japan 13 266 1.6× 90 0.7× 110 1.0× 37 0.5× 23 0.4× 47 526
Eisuke Suganuma Japan 11 76 0.5× 44 0.3× 79 0.7× 26 0.4× 58 1.0× 32 312

Countries citing papers authored by Xiqian Xing

Since Specialization
Citations

This map shows the geographic impact of Xiqian Xing's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiqian Xing with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiqian Xing more than expected).

Fields of papers citing papers by Xiqian Xing

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiqian Xing. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiqian Xing. The network helps show where Xiqian Xing may publish in the future.

Co-authorship network of co-authors of Xiqian Xing

This figure shows the co-authorship network connecting the top 25 collaborators of Xiqian Xing. A scholar is included among the top collaborators of Xiqian Xing based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiqian Xing. Xiqian Xing is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xu, Shuanglan, Qian Liu, Huilin He, et al.. (2025). Research progress on the application of nanomaterials in the diagnosis and treatment of venous thromboembolism. Nanomedicine Nanotechnology Biology and Medicine. 66. 102820–102820. 1 indexed citations
2.
Wu, J.‐Y., et al.. (2025). Modulation of Gut Microbiota by Traditional Chinese Medicine: A Novel Therapeutic Approach for Chronic Inflammatory Airway Diseases. The American Journal of Chinese Medicine. 53(7). 2043–2070. 1 indexed citations
3.
Wu, J.‐Y., Xiaolan Wang, Ting Liu, et al.. (2025). Revealing immune cell secretion crosstalk in pulmonary pathogenesis: A microfluidic lung-on-a-chip approach. International Journal of Pharmaceutics. 685. 126203–126203.
4.
Xie, Daxing, Lihui Zhang, Mengli Li, et al.. (2024). Bronchoscopic Closure of Bronchopleural Fistula with Occluder. Cancer Management and Research. Volume 16. 1851–1861.
5.
Xu, Shuanglan, et al.. (2024). Disordered gut microbiota and alterations in the serum metabolome are associated with venous thromboembolism. Thrombosis Research. 235. 68–74. 5 indexed citations
6.
Pan, Chunhong, et al.. (2023). Polyphyllin VII alleviates pulmonary hypertension by inducing miR-205–5p to target the β-catenin pathway. Biomedicine & Pharmacotherapy. 167. 115516–115516. 1 indexed citations
7.
Xing, Xiqian, et al.. (2023). Acute respiratory failure from an obstructive fibrinous tracheal pseudomembrane. Intensive Care Medicine. 49(4). 470–471. 1 indexed citations
8.
Han, Xiudi, Liang Chen, Hui Li, et al.. (2022). Prognostic Factors for Cardiovascular Events in Elderly Patients with Community Acquired Pneumonia: Results from the CAP-China Network. Clinical Interventions in Aging. Volume 17. 603–614. 2 indexed citations
9.
Liu, Jie, Yishu Deng, Shuanglan Xu, et al.. (2021). Construction and analysis of the abnormal lncRNA–miRNA–mRNA network in hypoxic pulmonary hypertension. Bioscience Reports. 41(8). 9 indexed citations
10.
Chen, Liang, Xiudi Han, Yanli Li, Chunxiao Zhang, & Xiqian Xing. (2021). The severity and risk factors for mortality in immunocompromised adult patients hospitalized with influenza-related pneumonia. Annals of Clinical Microbiology and Antimicrobials. 20(1). 55–55. 8 indexed citations
11.
Han, Xiudi, Liang Chen, Yimin Wang, et al.. (2021). Cost Effectiveness of Different Initial Antimicrobial Regimens for Elderly Community-Acquired Pneumonia Patients in General Ward. Infection and Drug Resistance. Volume 14. 1845–1853. 4 indexed citations
12.
Xing, Xiqian, Yishu Deng, Yun Zhu, et al.. (2020). Red cell distribution width for prognosis in patients with pulmonary embolism: A systematic review and meta‐analysis. The Clinical Respiratory Journal. 14(10). 901–907. 11 indexed citations
13.
Chen, Liang, Xiudi Han, Yanli Li, Chunxiao Zhang, & Xiqian Xing. (2020). Derivation and validation of a prediction rule for mortality of patients with respiratory virus-related pneumonia (RV-p score). Therapeutic Advances in Respiratory Disease. 14. 3272688820–3272688820. 2 indexed citations
14.
Liang, Chen, Xiudi Han, Yanli Li, Chunxiao Zhang, & Xiqian Xing. (2020). Severity and outcomes of influenza-related pneumonia in type A and B strains in China, 2013–2019. Infectious Diseases of Poverty. 9(1). 42–42. 13 indexed citations
15.
Xu, Shuanglan, Jiao Yang, Yun Zhu, et al.. (2019). CTPA, DECT, MRI, V/Q Scan, and SPECT/CT V/Q for the noninvasive diagnosis of chronic thromboembolic pulmonary hypertension. Medicine. 98(34). e16787–e16787. 6 indexed citations
16.
Zhou, Fuling, Xiqian Xing, Xiudi Han, et al.. (2018). [Clinical characteristics and prognosis of long-term glucocorticoid users with community-acquired pneumonia].. PubMed. 98(10). 738–743. 2 indexed citations
17.
Chen, Zihao, Jiangbo He, Xiqian Xing, et al.. (2018). Mn12Ac inhibits the migration, invasion and epithelial‑mesenchymal transition of lung cancer cells by downregulating the Wnt/β‑catenin and PI3K/AKT signaling pathways. Oncology Letters. 16(3). 3943–3948. 8 indexed citations
18.
Xu, Shuanglan, Jiao Yang, Shuangyan Xu, et al.. (2018). Lymphatic vessel density as a prognostic indicator in Asian NSCLC patients: a meta-analysis. BMC Pulmonary Medicine. 18(1). 128–128. 4 indexed citations
19.
Xing, Xiqian, Ye Gan, Shangjie Wu, et al.. (2006). Statins may ameliorate pulmonary hypertension via RhoA/Rho-kinase signaling pathway. Medical Hypotheses. 68(5). 1108–1113. 21 indexed citations
20.
Xing, Xiqian, et al.. (2006). Rho-kinase as a Potential Therapeutic Target for the Treatment of Pulmonary Hypertension. Drug News & Perspectives. 19(9). 517–517. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xin Feng Breakdown of academic impact, for papers by Goh Tanaka Breakdown of academic impact, for papers by Shigenori Tamaki Breakdown of academic impact, for papers by Yunjoo Im Breakdown of academic impact, for papers by Ying Feng Breakdown of academic impact, for papers by Sang-Min Kim Breakdown of academic impact, for papers by Ryan Brown Breakdown of academic impact, for papers by Tsutomu Hachiya Breakdown of academic impact, for papers by Eisuke Suganuma
Rankless by CCL
2026